Working Money magazine.  The investors' magazine.
Traders.com Advantage

INDICATORS LIST


LIST OF TOPICS





Article Archive | Search | Subscribe/Renew | Login | Free Trial | Forgot ID?


PRINT THIS ARTICLE

FLAGS AND PENNANTS


Viva Vivus!

07/15/05 11:50:50 AM
by Koos van der Merwe

Markos Katsanos has written a number of articles for Technical Analysis of STOCKS & COMMODITIES magazine demonstrating various strategies that I have found interesting. The strategy I'll use here to identify this stock is his flag and pennant recognition system, based on his article published in the May 2005 issue of STOCKS & COMMODITIES.

Security:   VVUS
Position:   N/A

Vivus Inc. (VVUS) develops therapies for the treatment of sexual dysfunction and urologic disorders in men and women. The company has developed two products to treat erectile dysfunction, which they market with Abbott Laboratories.

A 2005 chart of Vivus (VVUS) with various indicators.
Graphic provided by: MetaStock.
 
I identified this stock as a potential breakout candidate by using Katsanos's pattern-recognition formula that I programmed into MetaStock Explorer. The candlestick chart of Vivus includes various indicators that could be used to help decide whether to buy, including RSI, stochastics, and JM bands.

The chart shows how the price has moved up strongly from a low of $2.33 in May 2005 to a high of $4.15 by mid-June. The stock has now formed what looks like a pennant, with a move above the upper resistance line suggesting a target of $5.97 (4.15 - 2.33 = 1.82 + 4.15 = 5.97).

This point & figure chart of the close uses a three-box reversal. I calculate my target to be between $5.50 and $5.97.
Graphic provided by: MetaStock.
 
This point & figure chart of the close is a three-box reversal with a box size of 0.10. Using a horizontal count to determine a target, I reach a target of $5.50. (A move up will give six columns, x 3 = 18 x 0.1 = 1.8 + 3.70 = $5.50.) The target could then be between $5.50 and $5.97.

On the candlestick chart, I have drawn in some JM internal bands. JM internal bands are a 15-period moving average with a 2% positive and negative offset. Using the Advanced Explorer of MetaStock, I tested Vivus across a number of strategies. The JM strategy gave the third most profitable results, but was first in the smallest number of trades made.

I used MetaStock's Advanced Explorer to identify the best system to use on Vivus Inc. I ran the test on more than 400 days of data. Note that the JM internal band gave 8.602 points on 53 trades, compared to 190 trades for the strategy that offered the most points. Commissions paid would hurt this trade.
Graphic provided by: MetaStock.
 
Finally, note the two indicators plotted with the candlestick chart. The upper pane shows the RSI (14) suggesting weakness ahead, while the middle pane shows the stochastic RSI suggesting strength -- a conflict of indicators.

The pennant that could have formed is therefore the most obvious trigger -- that is, if you didn't already purchase the stock when the JM internal band signaled a buy. At the moment, the breakout level -- namely the upper resistance line -- is $3.73, with a move above the pivot point being a confirmation.



Koos van der Merwe

Has been a technical analyst since 1969, and has worked as a futures and options trader with First Financial Futures in Johannesburg, South Africa.

Address: 3256 West 24th Ave
Vancouver, BC
Phone # for sales: 6042634214
E-mail address: petroosp@gmail.com

Click here for more information about our publications!


Comments or Questions? Article Usefulness
5 (most useful)
4
3
2
1 (least useful)

Comments

Date: 07/19/05Rank: 2Comment: 
PRINT THIS ARTICLE





S&C Subscription/Renewal




Request Information From Our Sponsors 

DEPARTMENTS: Advertising | Editorial | Circulation | Contact Us | BY PHONE: (206) 938-0570

PTSK — The Professional Traders' Starter Kit
Home — S&C Magazine | Working Money Magazine | Traders.com Advantage | Online Store | Traders’ Resource
Add a Product to Traders’ Resource | Message Boards | Subscribe/Renew | Free Trial Issue | Article Code | Search

Copyright © 1982–2024 Technical Analysis, Inc. All rights reserved. Read our disclaimer & privacy statement.